Swiss National Bank cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,003,800 shares of the medical equipment provider's stock after selling 49,000 shares during the quarter. Swiss National Bank owned about 0.28% of Intuitive Surgical worth $523,943,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently bought and sold shares of the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $31,000. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth approximately $33,000. Finally, Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $36,000. 83.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have commented on ISRG. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Truist Financial increased their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. Finally, UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $613.10.
Get Our Latest Research Report on Intuitive Surgical
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now directly owns 2,091 shares of the company's stock, valued at approximately $1,114,879.38. The trade was a 18.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company's stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,209 shares of company stock worth $11,928,127 over the last quarter. 0.90% of the stock is owned by corporate insiders.
Intuitive Surgical Price Performance
ISRG opened at $497.30 on Thursday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business has a 50 day simple moving average of $569.42 and a two-hundred day simple moving average of $531.60. The firm has a market capitalization of $177.13 billion, a price-to-earnings ratio of 77.58, a PEG ratio of 5.85 and a beta of 1.43.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.